AtriCure Financial Statements From 2010 to 2024

ATRC Stock  USD 35.74  0.06  0.17%   
AtriCure financial statements provide useful quarterly and yearly information to potential AtriCure investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AtriCure financial statements helps investors assess AtriCure's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AtriCure's valuation are summarized below:
Gross Profit
245.9 M
Profit Margin
(0.09)
Market Capitalization
1.7 B
Enterprise Value Revenue
3.7737
Revenue
447.6 M
We have found one hundred twenty available fundamental signals for AtriCure, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of AtriCure's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. As of November 25, 2024, Market Cap is expected to decline to about 60.5 M. In addition to that, Enterprise Value is expected to decline to about 54.9 M

AtriCure Total Revenue

419.21 Million

Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.3 M, Total Revenue of 419.2 M or Gross Profit of 315.4 M, as well as many indicators such as Price To Sales Ratio of 3.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
  
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

AtriCure Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets644.6 M613.9 M349.6 M
Slightly volatile
Total Stockholder Equity489.5 M466.2 M237.1 M
Slightly volatile
Other Assets0.951.01.7 M
Pretty Stable
Common Stock Shares Outstanding24.2 M46.3 M29.9 M
Slightly volatile
Liabilities And Stockholders Equity644.6 M613.9 M349.6 M
Slightly volatile
Other Stockholder Equity865.4 M824.2 M455.4 M
Slightly volatile
Total Liabilities80.4 M147.8 M107.5 M
Slightly volatile
Other Current Liabilities46.9 M44.7 M22.4 M
Slightly volatile
Total Current Liabilities78.3 M74.6 M38.4 M
Slightly volatile
Accounts Payable28.7 M27.4 M13 M
Slightly volatile
Cash88.5 M84.3 M34.5 M
Slightly volatile
Inventory71.3 M67.9 M27.1 M
Slightly volatile
Other Current AssetsM8.6 M3.6 M
Slightly volatile
Common Stock28.1 K48 K32 K
Slightly volatile
Property Plant Equipment51.5 M49 M25.5 M
Slightly volatile
Property Plant And Equipment Net49.1 M46.8 M25.6 M
Slightly volatile
Non Current Assets Total365.1 M347.7 M214.3 M
Slightly volatile
Non Currrent Assets Other2.3 M2.2 M790.5 K
Slightly volatile
Cash And Short Term Investments144.1 M137.3 M80.2 M
Slightly volatile
Net Receivables55.1 M52.5 M25.2 M
Slightly volatile
Common Stock Total Equity28.2 K54 K32.4 K
Slightly volatile
Non Current Liabilities Total60 M73.2 M75.5 M
Slightly volatile
Property Plant And Equipment Gross104.1 M99.2 M32.8 M
Slightly volatile
Total Current Assets279.6 M266.2 M136 M
Slightly volatile
Short and Long Term Debt Total78.2 M74.5 M41.2 M
Slightly volatile
Long Term Debt63.6 M60.6 M31.2 M
Slightly volatile
Good Will283.5 M270 M132.6 M
Slightly volatile
Short Term Investments40.8 M53 M45.4 M
Slightly volatile
Short Term Debt2.2 M2.5 M2.3 M
Slightly volatile
Intangible Assets36.9 M64 M44.8 M
Slightly volatile
Other Liabilities1.3 M1.4 M35.4 M
Pretty Stable
Current Deferred Revenue978.9 K797.4 K1.1 M
Slightly volatile
Long Term Debt Total34.9 M65.4 M32.4 M
Slightly volatile
Capital Surpluse470.9 M905.5 M442.1 M
Slightly volatile
Non Current Liabilities Other1.2 M1.2 M39.1 M
Pretty Stable
Short and Long Term Debt3.3 M2.5 MM
Slightly volatile
Capital Lease Obligations10.4 M11.4 M13 M
Slightly volatile
Net Invested Capital447.1 M529.3 M306.2 M
Slightly volatile
Net Working Capital160.9 M191.7 M102.5 M
Slightly volatile
Capital Stock48.6 K48 K41.7 K
Slightly volatile

AtriCure Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue419.2 M399.2 M189.7 M
Slightly volatile
Gross Profit315.4 M300.4 M139.8 M
Slightly volatile
Other Operating Expenses447.2 M425.9 M214 M
Slightly volatile
Cost Of Revenue103.8 M98.9 M49.9 M
Slightly volatile
Total Operating Expenses343.4 M327.1 M164.1 M
Slightly volatile
Income Tax Expense797.4 K591 K413.4 K
Pretty Stable
Selling General Administrative265.8 M253.1 M117 M
Slightly volatile
Research Development77.6 M73.9 M35.4 M
Slightly volatile
Depreciation And Amortization15.6 M14.8 M7.8 M
Slightly volatile
Tax Provision620.5 K591 K165.1 K
Slightly volatile
Interest IncomeM3.8 M1.2 M
Slightly volatile
Reconciled Depreciation11.6 M14.8 M9.9 M
Slightly volatile
Non Recurring65.8 M74.1 M80.7 M
Slightly volatile

AtriCure Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures44.1 M42 M12.8 M
Slightly volatile
End Period Cash Flow88.5 M84.3 M34.5 M
Slightly volatile
Begin Period Cash Flow61 M58.1 M27.4 M
Slightly volatile
Depreciation15.6 M14.8 M7.8 M
Slightly volatile
Stock Based Compensation37.5 M35.7 M16.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.934.139787.769
Slightly volatile
PTB Ratio3.763.54545.8277
Slightly volatile
Days Sales Outstanding57.247.997851.5203
Slightly volatile
Book Value Per Share10.5710.06656.2219
Slightly volatile
Average PayablesM3.7 M3.7 M
Very volatile
Stock Based Compensation To Revenue0.05730.08950.0724
Slightly volatile
Capex To Depreciation2.982.83521.5589
Pretty Stable
PB Ratio3.763.54545.8277
Slightly volatile
EV To Sales3.914.115187.7895
Slightly volatile
Inventory Turnover2.661.45622.3968
Slightly volatile
Days Of Inventory On Hand130251165
Slightly volatile
Payables Turnover4.373.61464.1419
Very volatile
Sales General And Administrative To Revenue0.780.740.683
Very volatile
Average Inventory3.8 M5.5 M5.6 M
Pretty Stable
Research And Ddevelopement To Revenue0.220.18510.191
Very volatile
Capex To Revenue0.110.10520.0632
Very volatile
Cash Per Share1.722.96452.2205
Slightly volatile
Days Payables Outstanding11010194.8375
Very volatile
Intangibles To Total Assets0.260.48660.3855
Slightly volatile
Current Ratio3.83.57053.3154
Slightly volatile
Receivables Turnover5.727.60457.1683
Slightly volatile
Graham Number14.0912.201310.3905
Slightly volatile
Shareholders Equity Per Share10.5710.06656.2219
Slightly volatile
Debt To Equity0.190.13540.1769
Pretty Stable
Capex Per Share0.950.90690.3978
Pretty Stable
Average Receivables4.5 M7.5 M7.6 M
Pretty Stable
Revenue Per Share9.058.62135.2939
Slightly volatile
Interest Debt Per Share1.591.51270.9268
Slightly volatile
Debt To Assets0.07360.10280.0937
Very volatile
Operating Cycle172299216
Slightly volatile
Price Book Value Ratio3.763.54545.8277
Slightly volatile
Days Of Payables Outstanding11010194.8375
Very volatile
Company Equity Multiplier1.11.3171.5893
Slightly volatile
Long Term Debt To Capitalization0.0880.1150.1264
Pretty Stable
Total Debt To Capitalization0.10.11930.1324
Pretty Stable
Debt Equity Ratio0.190.13540.1769
Pretty Stable
Quick Ratio3.172.65992.7089
Slightly volatile
Net Income Per E B T1.111.01981.0116
Slightly volatile
Cash Ratio1.251.13060.8946
Very volatile
Cash Conversion Cycle208198130
Slightly volatile
Days Of Inventory Outstanding130251165
Slightly volatile
Days Of Sales Outstanding57.247.997851.5203
Slightly volatile
Price To Book Ratio3.763.54545.8277
Slightly volatile
Fixed Asset Turnover12.368.538410.1231
Slightly volatile
Debt Ratio0.07360.10280.0937
Very volatile
Price Sales Ratio3.934.139787.769
Slightly volatile
Asset Turnover0.940.65030.7363
Slightly volatile
Gross Profit Margin0.580.75230.7097
Pretty Stable
Price Fair Value3.763.54545.8277
Slightly volatile

AtriCure Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.5 M79.2 M81.3 M
Pretty Stable
Enterprise Value54.9 M73.6 M75.6 M
Pretty Stable

AtriCure Fundamental Market Drivers

Cash And Short Term Investments137.3 M

AtriCure Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's revenue or net income, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue797.4 K978.9 K
Total Revenue399.2 M419.2 M
Cost Of Revenue98.9 M103.8 M
Stock Based Compensation To Revenue 0.09  0.06 
Sales General And Administrative To Revenue 0.74  0.78 
Research And Ddevelopement To Revenue 0.19  0.22 
Capex To Revenue 0.11  0.11 
Revenue Per Share 8.62  9.05 
Ebit Per Revenue(0.07)(0.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
9.564
Quarterly Revenue Growth
0.179
Return On Assets
(0.04)
Return On Equity
(0.08)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.